Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when PMI files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Departure of CFO (new) — The CFO was terminated immediately with no explanation provided, which may signal financial or operational issues.
Picard Medical terminates CFO Bernard Skaggs immediately, appoints Georgina Smith as CAO
Filed June 2, 2026 · Period ending June 1, 2026 · ~1 min read
Key Changes
-
high
CFO Bernard Skaggs was terminated effective immediately on June 1, 2026, with no explanation provided in the filing—an unusual omission that may signal financial disagreements or performance issues.
Item 5.02 verify on EDGAR → -
medium
Georgina Smith, 54, appointed Chief Accounting Officer effective June 1. She previously served as Controller at subsidiary SynCardia (Jan-May 2026) and held accounting roles at Rain Bird and Tucson Electric Power.
Item 5.02 verify on EDGAR →
Summary
Picard Medical disclosed the immediate termination of CFO Bernard Skaggs on June 1, 2026, without providing any rationale for the departure. The lack of explanation is notable—companies typically disclose whether executives leave for personal reasons, performance issues, or disagreements over financial matters.
The abrupt nature and silence around the termination raises questions about potential financial reporting concerns or strategic disagreements at the executive level. Simultaneously, the company appointed Georgina Smith as Chief Accounting Officer. Smith brings relevant experience, including a recent stint as Controller at Picard's SynCardia subsidiary and prior roles at established companies.
However, she steps into the CAO role during a period of apparent financial leadership instability. Retail investors should watch for the company's next quarterly earnings report and any amendments to prior financial statements. If the CFO departure relates to accounting disagreements, subsequent disclosures or restatements could materially impact the stock. Monitor for any follow-up 8-K filings or management commentary explaining the circumstances of Skaggs' termination.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
Also as of June 1, 2026, Bernard Skaggs was terminated as the Chief Financial Officer of Picard Medical, Inc. (the “Company”), effective immediately.
The company terminated its Chief Financial Officer Bernard Skaggs effective immediately on June 1, 2026. The 8-K provides no explanation for the termination, which is unusual for a senior executive departure and may indicate disagreements over financial matters, performance issues, or other concerns.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify